Skip to main content
Log in

Synoviale Biomarker für die Differenzialdiagnostik der schmerzhaften Endoprothese

Synovial biomarkers for differential diagnosis of painful arthroplasty

  • Leitthema
  • Published:
Der Orthopäde Aims and scope Submit manuscript

Zusammenfassung

Hintergrund

Der periprothetische Gelenkinfekt (PPI) gilt als große diagnostische und therapeutische Herausforderung. Er schmälert den Therapieerfolg, stellt eine enorme Belastung für die betroffenen Patienten dar und zieht häufig aufwendige operative Revisionen nach sich. Ein schrittweises aufwendiges diagnostisches Vorgehen ist hier bisher angezeigt, um zeit- und kostenintensive Irrläufe zu vermeiden. Die gegenwärtige (Gold-)Standarddiagnostik kommt jedoch insbesondere beim häufigen und klinisch relevanten chronischen „low-grade“-PPI an ihre Grenzen.

Einschätzung

Synoviale Biomarker zur sicheren Differenzierung einer aseptischen von der (chronischen) septischen sowie der implantatallergischen Beschwerdeursache und der Arthrofibrose werden momentan zur Überwindung der diagnostischen Lücke favorisiert. Die ambulant durchführbare Synovialpunktion ist dabei der operativen Synovial-(is-)Biopsie bei früherem Diagnosezeitpunkt, höherer Alltagspraktikabilität, geringerer Patientengefährdung und schließlich geringeren Kosten überlegen. Neben Parametern wie Interleukin-6 (IL-6), C-reaktives Protein (CRP) und Leukozytenesterase in der Gelenkflüssigkeit gelten innovative synoviale Biomarker aus der Gruppe der antimikrobiellen Peptide und proinflammatorischen Zytokine aufgrund sehr guter bis exzellenter diagnostischer Genauigkeit als besonders vielversprechend.

Schlussfolgerung

Welches (differenzial-)diagnostische Set verschiedener Biomarker bei der innovativen „one-stop-shop“-Strategie der synovialen Infektdiagnostik künftig zu favorisieren ist, müssen unabhängige Multicenter-Validierungsstudien zeigen.

Abstract

Background

The diagnosis and treatment of periprosthetic joint infection (PJI) remain true clinical challenges. PJI diminishes therapeutic success, causes dissatisfaction for the patient and medical staff, and often requires extensive surgical revision(s). At the present time, an extensive multimodal algorithmic approach is used to avoid time- and cost-consuming diagnostic aberrations. However, especially in the case of the frequent and clinically most relevant “low-grade” PJI, the current diagnostic “gold standard” has reached its limits.

Evaluation

Synovial biomarkers are thought to close this diagnostic gap, hopefully enabling the safe differentiation among aseptic, (chronic) septic, implant allergy-related and the arthrofibrotic genesis of symptomatic arthroplasty. Therefore, joint aspiration for obtaining synovial fluid is preferred over surgical synovial tissue biopsy because of the faster results, greater practicability, greater patient safety, and lower costs. In addition to the parameters synovial IL-6, CRP, and leukocyte esterase, novel biomarkers such as antimicrobial peptides and other proinflammatory cytokines are currently highlighted because of their very high to excellent diagnostic accuracy.

Conclusion

Independent multicenter validation studies are required to show whether a set of different innovative synovial fluid biomarkers rather than a few single parameters is favorable for a safe “one-stop shop” differential diagnosis of PJI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Banke IJ, von Eisenhart-Rothe R, Gollwitzer H (2014) Innovationen in der synovialen Diagnostik bei schmerzhafter Knieendoprothese. Management Krankenhaus Kompakt Ortho Trauma 4:12–13

    Google Scholar 

  2. Bosch U (2002) [Arthrofibrosis]. Orthopäde 31:785–790

  3. Bosch U, Zeichen J, Lobenhoffer P et al (1999) Arthrofibrose – Ein chronischer inflammatorischer Prozeß? Arthroskopie 12:117–120

    Article  Google Scholar 

  4. Bosch U, Zeichen J, Lobenhoffer P et al (1999) Ätiologie der Arthrofibrose. Arthroskopie 12:215–221

    Article  Google Scholar 

  5. Bosch U, Zeichen J, Skutek M et al (2001) Arthrofibrosis is the result of a T cell mediated immune response. Knee Surg Sports Traumatol Arthrosc 9:282–289

    Article  CAS  PubMed  Google Scholar 

  6. Chen A, Fei J, Deirmengian C (2014) Diagnosis of periprosthetic infection: novel developments. J Knee Surg 27:259–265

    Article  PubMed  Google Scholar 

  7. Chen AF, Heller S, Parvizi J (2014) Prosthetic joint infections. Surg Clin North Am 94:1265–1281

    Article  PubMed  Google Scholar 

  8. Cipriano CA, Brown NM, Michael AM et al (2012) Serum and synovial fluid analysis for diagnosing chronic periprosthetic infection in patients with inflammatory arthritis. J Bone Joint Surg Am 94:594–600

    Article  PubMed  Google Scholar 

  9. Classen T, Zaps D, Landgraeber S et al (2013) Assessment and management of chronic pain in patients with stable total hip arthroplasty. Int Orthop 37:1–7

    Article  PubMed Central  PubMed  Google Scholar 

  10. Deirmengian C, Hallab N, Tarabishy A et al (2010) Synovial fluid biomarkers for periprosthetic infection. Clin Orthop Relat Res 468:2017–2023

    Article  PubMed Central  PubMed  Google Scholar 

  11. Deirmengian C, Kardos K, Kilmartin P et al (2015) The alpha-defensin test for periprosthetic joint infection outperforms the leukocyte esterase test strip. Clin Orthop Relat Res 473:198–203

    Article  PubMed Central  PubMed  Google Scholar 

  12. Deirmengian C, Kardos K, Kilmartin P et al (2014) Combined measurement of synovial fluid alpha-Defensin and C-reactive protein levels: highly accurate for diagnosing periprosthetic joint infection. J Bone Joint Surg Am 96:1439–1445

    Article  PubMed  Google Scholar 

  13. Deirmengian C, Kardos K, Kilmartin P et al (2014) Diagnosing periprosthetic joint infection: has the era of the biomarker arrived? Clin Orthop Relat Res 472:3254–3262

    Article  PubMed Central  PubMed  Google Scholar 

  14. Deirmengian C, Kardos K, Kilmartin P et al (2015) The alpha-defensin test for periprosthetic joint infection responds to a wide spectrum of organisms. Clin Orthop Relat Res 473:2229–2235

    Article  PubMed Central  PubMed  Google Scholar 

  15. Faust I, Traut P, Nolting F et al (2015) Human xylosyltransferases – mediators of arthrofibrosis? New pathomechanistic insights into arthrofibrotic remodeling after knee replacement therapy. Sci Rep 5:12537

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Gollwitzer H, Burgkart R, Diehl P et al (2006) [Therapy of arthrofibrosis after total knee arthroplasty]. Orthopäde 35:143–152

    Article  CAS  PubMed  Google Scholar 

  17. Gollwitzer H, Diehl P, Gerdesmeyer L et al (2006) [Diagnostic strategies in cases of suspected periprosthetic infection of the knee. A review of the literature and current recommendations]. Orthopäde 35:904–916

    Article  CAS  PubMed  Google Scholar 

  18. Gollwitzer H, Dombrowski Y, Prodinger PM et al (2013) Antimicrobial peptides and proinflammatory cytokines in periprosthetic joint infection. J Bone Joint Surg Am 95:644–651

    Article  PubMed  Google Scholar 

  19. Hansen EN, Zmistowski B, Parvizi J (2012) Periprosthetic joint infection: what is on the horizon? Int J Artif Organs 35:935–950

    CAS  PubMed  Google Scholar 

  20. Hofmann S, Seitlinger G, Djahani O et al (2011) The painful knee after TKA: a diagnostic algorithm for failure analysis. Knee Surg Sports Traumatol Arthrosc 19:1442–1452

    Article  CAS  PubMed  Google Scholar 

  21. Jacovides CL, Parvizi J, Adeli B et al (2011) Molecular markers for diagnosis of periprosthetic joint infection. J Arthroplasty 26:99–103e101

    Article  PubMed  Google Scholar 

  22. Krenn V, Morawietz L, Perino G et al (2014) Revised histopathological consensus classification of joint implant related pathology. Pathol Res Pract 210:779–786

    Article  CAS  PubMed  Google Scholar 

  23. Krenn V, Ruppert M, Knoss P et al (2013) [Synovialitis of the arthrofibrotic type: criteria of a new synovialitis type for the diagnosis of arthrofibrosis]. Z Rheumatol 72:270–278

    Article  CAS  PubMed  Google Scholar 

  24. Lindblad S, Klareskog L, Hedfors E et al (1983) Phenotypic characterization of synovial tissue cells in situ in different types of synovitis. Arthritis Rheum 26:1321–1332

    Article  CAS  PubMed  Google Scholar 

  25. Muhlhofer HM, Gollwitzer H, Lenze F et al (2015) [Periprosthetic infections of the hip joint: clinical approach]. Orthopäde 44:357–365

    Article  CAS  PubMed  Google Scholar 

  26. Nodzo SR, Bauer T, Pottinger PS et al (2015) Conventional diagnostic challenges in periprosthetic joint infection. J Am Acad Orthop Surg 23(Suppl):S18–S25

    Article  PubMed  Google Scholar 

  27. Parvizi J (2015) Periprosthetic joint infection: the last frontier. Bone Joint J 97-B:1157–1158

    Article  CAS  PubMed  Google Scholar 

  28. Parvizi J, Alijanipour P, Barberi EF et al (2015) Novel developments in the prevention, diagnosis, and treatment of periprosthetic joint infections. J Am Acad Orthop Surg 23(Suppl):S32–S43

    Article  PubMed  Google Scholar 

  29. Parvizi J, Heller S, Berend KR et al (2015) Periprosthetic joint infection: the algorithmic approach and emerging evidence. Instr Course Lect 64:51–60

    PubMed  Google Scholar 

  30. Pfitzner T, Geissler S, Duda G et al (2012) Increased BMP expression in arthrofibrosis after TKA. Knee Surg Sports Traumatol Arthrosc 20:1803–1808

    Article  PubMed  Google Scholar 

  31. Randau TM, Friedrich MJ, Wimmer MD et al (2014) Interleukin-6 in serum and in synovial fluid enhances the differentiation between periprosthetic joint infection and aseptic loosening. PLoS One 9:e89045

    Article  PubMed Central  PubMed  Google Scholar 

  32. Singh G, Nuechtern JV, Meyer H et al (2015) Particle characterisation and cytokine expression in failed small-diameter metal-on-metal total hip arthroplasties. Bone Joint J 97-B:917–923

    Article  CAS  PubMed  Google Scholar 

  33. Ständer S, Thomas P, Rueff F et al (2014) Comparative assessment of nickel sensitization based on medical history, patch test and lymphocyte transformation test. Allergo J Int 23:35–53

    Article  Google Scholar 

  34. Summer B, Paul C, Mazoochian F et al (2010) Nickel (Ni) allergic patients with complications to Ni containing joint replacement show preferential IL-17 type reactivity to Ni. Contact Dermatitis 63:15–22

    Article  CAS  PubMed  Google Scholar 

  35. Tetreault MW, Wetters NG, Moric M et al (2014) Is synovial C-reactive protein a useful marker for periprosthetic joint infection? Clin Orthop Relat Res 472:3997–4003

    Article  PubMed  Google Scholar 

  36. Thomas B, Kulichova D, Wolf R et al (2015) High frequency of contact allergy to implant and bone cement components, in particular gentamicin, in cemented arthroplasty with complications: usefulness of late patch test reading. Contact Dermatitis (im Druck)

  37. Thomas P, Braathen LR, Dorig M et al (2009) Increased metal allergy in patients with failed metal-on-metal hip arthroplasty and peri-implant T-lymphocytic inflammation. Allergy 64:1157–1165

    Article  CAS  PubMed  Google Scholar 

  38. Thomas P, Geier J, Dickel H et al (2015) DKG-Stellungnahme zur Epikutantestung von Metalllegierungsplättchen bei Verdacht auf Metallimplantat-Unverträglichkeit Orthopäde. doi:10.1007/s00132-015-3150-8

  39. Thomas P, Iglhaut G, Wollenberg A et al (2013) Allergy or tolerance: reduced inflammatory cytokine response and concomitant IL-10 production of lymphocytes and monocytes in symptom-free titanium dental implant patients. Biomed Res Int 2013:539834

    PubMed Central  PubMed  Google Scholar 

  40. Thomas P, Roider G, Beraudi A et al (2015) Metal implant allergy and immuno-allergological compatibility aspects of ceramic materials. Springer Medizin; Clinical management guide series, Berlin

    Google Scholar 

  41. Thomas P, Schuh A, Ring J et al (2008) [Orthopedic surgical implants and allergies: joint statement by the implant allergy working group (AK 20) of the DGOOC (German association of orthopedics and orthopedic surgery), DKG (German contact dermatitis research group) and dgaki (German society for allergology and clinical immunology)]. Orthopade 37:75–88

    Article  CAS  PubMed  Google Scholar 

  42. Thomas P, Summer B (2015) Diagnosis and management of patients with allergy to metal implants. Expert Rev Clin Immunol 11:501–509

    Article  CAS  PubMed  Google Scholar 

  43. Thomas P, Summer B, Krenn V et al (2013) [Allergy diagnostics in suspected metal implant intolerance]. Orthopade 42:602–606

    Article  CAS  PubMed  Google Scholar 

  44. Thomas P, Von Der Helm C, Schopf C et al (2015) Patients with intolerance reactions to total knee replacement: combined assessment of allergy diagnostics, periprosthetic histology, and peri-implant cytokine expression pattern. Biomed Res Int 2015:910156

    PubMed Central  PubMed  Google Scholar 

  45. Unterhauser FN, Bosch U, Zeichen J et al (2004) Alpha-smooth muscle actin containing contractile fibroblastic cells in human knee arthrofibrosis tissue. Winner of the AGA-DonJoy Award 2003. Arch Orthop Trauma Surg 124:585–591

    Article  PubMed  Google Scholar 

  46. Varoga D, Pufe T, Mentlein R et al (2005) Expression and regulation of antimicrobial peptides in articular joints. Ann Anat 187:499–508

    Article  CAS  PubMed  Google Scholar 

  47. Willert HG, Buchhorn GH, Fayyazi A et al (2005) Metal-on-metal bearings and hypersensitivity in patients with artificial hip joints. A clinical and histomorphological study. J Bone Joint Surg Am 87:28–36

    Article  PubMed  Google Scholar 

  48. Zeichen J, Van Griensven M, Albers I et al (1999) Immunohistochemical localization of collagen VI in arthrofibrosis. Arch Orthop Trauma Surg 119:315–318

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I.J. Banke.

Ethics declarations

Interessenkonflikt

I. J. Banke, N. Stade, P. M. Prodinger, H. M. Mühlhofer, P. Thomas, B. Thomas, B. Summer, M. van Griensven, R. von Eisenhart-Rothe und H. Gollwitzer geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Banke, I., Stade, N., Prodinger, P. et al. Synoviale Biomarker für die Differenzialdiagnostik der schmerzhaften Endoprothese. Orthopäde 44, 934–941 (2015). https://doi.org/10.1007/s00132-015-3188-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00132-015-3188-7

Schlüsselwörter

Keywords

Navigation